548 related articles for article (PubMed ID: 27855650)
1. Trimetazidine attenuates pressure overload-induced early cardiac energy dysfunction via regulation of neuropeptide Y system in a rat model of abdominal aortic constriction.
Chen A; Li W; Chen X; Shen Y; Dai W; Dong Q; Li X; Ou C; Chen M
BMC Cardiovasc Disord; 2016 Nov; 16(1):225. PubMed ID: 27855650
[TBL] [Abstract][Full Text] [Related]
2. Metformin Improves Cardiac Metabolism and Function, and Prevents Left Ventricular Hypertrophy in Spontaneously Hypertensive Rats.
Li J; Minćzuk K; Massey JC; Howell NL; Roy RJ; Paul S; Patrie JT; Kramer CM; Epstein FH; Carey RM; Taegtmeyer H; Keller SR; Kundu BK
J Am Heart Assoc; 2020 Apr; 9(7):e015154. PubMed ID: 32248762
[TBL] [Abstract][Full Text] [Related]
3. Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy.
Zhang L; Jaswal JS; Ussher JR; Sankaralingam S; Wagg C; Zaugg M; Lopaschuk GD
Circ Heart Fail; 2013 Sep; 6(5):1039-48. PubMed ID: 23861485
[TBL] [Abstract][Full Text] [Related]
4. A novel traditional Chinese medicine ameliorates fatigue-induced cardiac hypertrophy and dysfunction via regulation of energy metabolism.
Huang R; Cui YC; Wei XH; Pan CS; Li Q; He SY; Fan JY; Han JY
Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1378-H1388. PubMed ID: 30951366
[TBL] [Abstract][Full Text] [Related]
5. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
Gao S; Long CL; Wang RH; Wang H
Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone attenuates myocardial fibrosis in rats with chronic pressure overload-induced left ventricular hypertrophy.
Moreira VO; Pereira CA; Silva MO; Felisbino SL; Cicogna AC; Okoshi K; Aragon FF; Padovani CR; Okoshi MP; Castro AV
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):325-30. PubMed ID: 19278522
[TBL] [Abstract][Full Text] [Related]
7. Curcumin inhibits cardiac hypertrophy and improves cardiovascular function via enhanced Na
Bai XJ; Hao JT; Wang J; Zhang WF; Yan CP; Zhao JH; Zhao ZQ
Pharmacol Rep; 2018 Feb; 70(1):60-68. PubMed ID: 29331788
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide Y mediates cardiac hypertrophy through microRNA-216b/FoxO4 signaling pathway.
Wang J; Hao D; Zeng L; Zhang Q; Huang W
Int J Med Sci; 2021; 18(1):18-28. PubMed ID: 33390770
[TBL] [Abstract][Full Text] [Related]
9. Differential cardiac hypertrophy and signaling pathways in pressure versus volume overload.
You J; Wu J; Zhang Q; Ye Y; Wang S; Huang J; Liu H; Wang X; Zhang W; Bu L; Li J; Lin L; Ge J; Zou Y
Am J Physiol Heart Circ Physiol; 2018 Mar; 314(3):H552-H562. PubMed ID: 29196344
[TBL] [Abstract][Full Text] [Related]
10. Trimetazidine suppresses oxidative stress, inhibits MMP-2 and MMP-9 expression, and prevents cardiac rupture in mice with myocardial infarction.
Gong W; Ma Y; Li A; Shi H; Nie S
Cardiovasc Ther; 2018 Oct; 36(5):e12460. PubMed ID: 30019466
[TBL] [Abstract][Full Text] [Related]
11. Alamandine improves cardiac remodeling induced by transverse aortic constriction in mice.
Silva MM; de Souza-Neto FP; Jesus ICG; Gonçalves GK; Santuchi MC; Sanches BL; de Alcântara-Leonídio TC; Melo MB; Vieira MAR; Guatimosim S; Santos RAS; da Silva RF
Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H352-H363. PubMed ID: 33124885
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibition has cardiac and vascular protective effects in rats with pressure overload cardiac hypertrophy.
Jung H; Lee E; Kim I; Song JH; Kim GJ
Physiol Res; 2019 Oct; 68(5):727-737. PubMed ID: 31424255
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial Reversible Changes Determine Diastolic Function Adaptations During Myocardial (Reverse) Remodeling.
Miranda-Silva D; G Rodrigues P; Alves E; Rizo D; Fonseca ACRG; Lima T; Baganha F; Conceição G; Sousa C; Gonçalves A; Miranda I; Vasques-Nóvoa F; Magalhães J; Leite-Moreira A; Falcão-Pires I
Circ Heart Fail; 2020 Nov; 13(11):e006170. PubMed ID: 33176457
[TBL] [Abstract][Full Text] [Related]
14. Changes in cardiac structure and function in a modified rat model of myocardial hypertrophy.
Dai W; Dong Q; Chen M; Zhao L; Chen A; Li Z; Liu S
Cardiovasc J Afr; 2016; 27(3):134-142. PubMed ID: 27841899
[TBL] [Abstract][Full Text] [Related]
15. Baicalin Attenuates Cardiac Dysfunction and Myocardial Remodeling in a Chronic Pressure-Overload Mice Model.
Zhang Y; Liao P; Zhu M; Li W; Hu D; Guan S; Chen L
Cell Physiol Biochem; 2017; 41(3):849-864. PubMed ID: 28214892
[TBL] [Abstract][Full Text] [Related]
16. Combination Treatment With Antihypertensive Agents Enhances the Effect of Qiliqiangxin on Chronic Pressure Overload-induced Cardiac Hypertrophy and Remodeling in Male Mice.
Ye Y; Gong H; Wang X; Wu J; Wang S; Yuan J; Yin P; Jiang G; Li Y; Ding Z; Zhang W; Zhou J; Ge J; Zou Y
J Cardiovasc Pharmacol; 2015 Jun; 65(6):628-39. PubMed ID: 25806688
[TBL] [Abstract][Full Text] [Related]
17. Abnormalities in lysine degradation are involved in early cardiomyocyte hypertrophy development in pressure-overloaded rats.
Liu J; Hu J; Tan L; Zhou Q; Wu X
BMC Cardiovasc Disord; 2021 Aug; 21(1):403. PubMed ID: 34418957
[TBL] [Abstract][Full Text] [Related]
18. Disruption of actin dynamics regulated by Rho effector mDia1 attenuates pressure overload-induced cardiac hypertrophic responses and exacerbates dysfunction.
Abe I; Terabayashi T; Hanada K; Kondo H; Teshima Y; Ishii Y; Miyoshi M; Kira S; Saito S; Tsuchimochi H; Shirai M; Yufu K; Arakane M; Daa T; Thumkeo D; Narumiya S; Takahashi N; Ishizaki T
Cardiovasc Res; 2021 Mar; 117(4):1103-1117. PubMed ID: 32647865
[TBL] [Abstract][Full Text] [Related]
19. The GABA
Bu J; Huang S; Wang J; Xia T; Liu H; You Y; Wang Z; Liu K
Front Immunol; 2021; 12():670153. PubMed ID: 34135897
[TBL] [Abstract][Full Text] [Related]
20. Effects of Xin-Ji-Er-Kang formula on 2K1C-induced hypertension and cardiovascular remodeling in rats.
Guo K; Lan CZ; Yu TT; Huang LL; Wang XH; Pan C; Gao S
J Ethnopharmacol; 2014 Sep; 155(2):1227-35. PubMed ID: 25063306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
